Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9404401 | 0.79 | CHRM2 (0.46) | MAOAMAOB | |
| SCHEMBL9404405 | 0.79 | CHRM2 (0.46) | MAOAMAOB | |
| SCHEMBL9625300 | 0.67 | FAAH (0.46) | — | |
| SCHEMBL12867629 | 0.64 | ADRA2A (0.33) | MAOAMAOB | |
| SCHEMBL19243978 | 0.63 | ALDH1A1 (0.34) | MAOAMAOB | |
| SCHEMBL21323127 | 0.62 | MEN1 (0.37) | MAOAMAOB | |
| SCHEMBL16686670 | 0.61 | MAOA (0.49) | MAOAMAOB | |
| SCHEMBL16686672 | 0.61 | MAOA (0.49) | MAOAMAOB | |
| SCHEMBL9009633 | 0.60 | CHRM2 (0.64) | — | |
| SCHEMBL9009653 | 0.60 | CHRM2 (0.64) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0316718-B1 | AZACYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1993-09-15 | — | — | EP | claimed |
| US-5356912-A | 3-(5-isoxazolyl)-1-methyl-1,2,3,6-tetrahydropyridine useful for treating Alzheimer's disease | NOVO NORDISK A/S (DK) | 1994-10-18 | — | — | US | disclosed |
| US-5262427-A | Cognition activators for Alzheimer*s disease | NOVO NORDISK A/S (DK) | 1993-11-16 | — | — | US | disclosed |
| EP-0316718-B1 | AZACYCLIC COMPOUNDS AND THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1993-09-15 | — | — | EP | disclosed |
| EP-0316718-A2 | Azacyclic compounds and their preparation and use | NOVO NORDISK A/S (DK) | 1989-05-24 | — | — | EP | disclosed |